# Topical Steroids and Cyclosporin-A for COVID-19 Keratoconjunctivitis

> **NCT04451239** · NA · UNKNOWN · sponsor: **Ameera Gamal Abdelhameed** · enrollment: 12 (estimated)

## Conditions studied

- Keratonjunctivitis

## Interventions

- **DRUG:** topical steroids and cyclosporin-A

## Key facts

- **NCT ID:** NCT04451239
- **Lead sponsor:** Ameera Gamal Abdelhameed
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-06-30
- **Primary completion:** 2020-07
- **Final completion:** 2020-07
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2020-06-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04451239

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04451239, "Topical Steroids and Cyclosporin-A for COVID-19 Keratoconjunctivitis". Retrieved via AI Analytics 2026-09-15 from https://api.ai-analytics.org/clinical/NCT04451239. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*